BPMC
Lazard Asset Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $172K | Sell |
1,348
-15,864
| -92% | -$2.02M | ﹤0.01% | 1737 |
|
|
2025
Q1 | $1.52M | Buy |
17,212
+15,834
| +1,149% | +$1.4M | ﹤0.01% | 1057 |
|
|
2024
Q4 | $118K | Sell |
1,378
-8,772
| -86% | -$751K | ﹤0.01% | 1751 |
|
|
2024
Q3 | $937K | Buy |
10,150
+4,485
| +79% | +$414K | ﹤0.01% | 1104 |
|
|
2024
Q2 | $610K | Buy |
5,665
+3,007
| +113% | +$324K | ﹤0.01% | 1126 |
|
|
2024
Q1 | $251K | Buy |
+2,658
| New | +$251K | ﹤0.01% | 1232 |
|
|
2023
Q3 | – | Sell |
-1,103
| Closed | -$69K | – | 2272 |
|
|
2023
Q2 | $69K | Buy |
+1,103
| New | +$69K | ﹤0.01% | 1720 |
|
|
2023
Q1 | – | Sell |
-1,312
| Closed | -$57K | – | 2308 |
|
|
2022
Q4 | $57K | Buy |
+1,312
| New | +$57K | ﹤0.01% | 1737 |
|
|
2021
Q4 | – | Sell |
-11,277
| Closed | -$1.16M | – | 2299 |
|
|
2021
Q3 | $1.16M | Buy |
+11,277
| New | +$1.16M | ﹤0.01% | 1041 |
|
|
2021
Q1 | – | Sell |
-824
| Closed | -$92K | – | 1863 |
|
|
2020
Q4 | $92K | Buy |
+824
| New | +$92K | ﹤0.01% | 1204 |
|